vs
Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Tonix Pharmaceuticals Holding Corp. (TNXP). Click either name above to swap in a different company.
CHICAGO RIVET & MACHINE CO is the larger business by last-quarter revenue ($6.0M vs $5.4M, roughly 1.1× Tonix Pharmaceuticals Holding Corp.). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -870.3%, a 851.0% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs 45.9%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-41.5M). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs -12.7%).
Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
CVR vs TNXP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $6.0M | $5.4M |
| Net Profit | $-1.2M | $-46.9M |
| Gross Margin | 2.7% | 80.4% |
| Operating Margin | -15.3% | -895.8% |
| Net Margin | -19.3% | -870.3% |
| Revenue YoY | 45.9% | 108.8% |
| Net Profit YoY | 68.0% | -112.2% |
| EPS (diluted) | — | $-4.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.0M | $5.4M | ||
| Q3 25 | $7.4M | $3.3M | ||
| Q2 25 | $7.3M | $2.0M | ||
| Q1 25 | $7.2M | $2.4M | ||
| Q4 24 | $4.1M | $2.6M | ||
| Q3 24 | $7.0M | $2.8M | ||
| Q2 24 | $8.1M | $2.2M | ||
| Q1 24 | $7.9M | $2.5M |
| Q4 25 | $-1.2M | $-46.9M | ||
| Q3 25 | $67.6K | $-32.0M | ||
| Q2 25 | $-395.0K | $-28.3M | ||
| Q1 25 | $401.0K | $-16.8M | ||
| Q4 24 | $-3.6M | $-22.1M | ||
| Q3 24 | $-1.4M | $-14.2M | ||
| Q2 24 | $142.1K | $-78.8M | ||
| Q1 24 | $-698.0K | $-14.9M |
| Q4 25 | 2.7% | 80.4% | ||
| Q3 25 | 18.1% | 58.4% | ||
| Q2 25 | 13.4% | -63.8% | ||
| Q1 25 | 22.9% | 61.2% | ||
| Q4 24 | -43.7% | 54.2% | ||
| Q3 24 | 10.0% | 44.9% | ||
| Q2 24 | 17.6% | -52.5% | ||
| Q1 24 | 9.5% | 33.1% |
| Q4 25 | -15.3% | -895.8% | ||
| Q3 25 | 0.9% | -1005.1% | ||
| Q2 25 | -5.7% | -1416.2% | ||
| Q1 25 | 1.0% | -660.9% | ||
| Q4 24 | -86.4% | -870.6% | ||
| Q3 24 | -11.8% | -551.2% | ||
| Q2 24 | 1.3% | -3501.6% | ||
| Q1 24 | -11.5% | -860.2% |
| Q4 25 | -19.3% | -870.3% | ||
| Q3 25 | 0.9% | -972.9% | ||
| Q2 25 | -5.4% | -1415.0% | ||
| Q1 25 | 5.5% | -692.8% | ||
| Q4 24 | -88.0% | -856.2% | ||
| Q3 24 | -20.8% | -503.6% | ||
| Q2 24 | 1.8% | -3567.8% | ||
| Q1 24 | -8.9% | -601.9% |
| Q4 25 | — | $-4.28 | ||
| Q3 25 | — | $-3.59 | ||
| Q2 25 | — | $-3.86 | ||
| Q1 25 | — | $-2.84 | ||
| Q4 24 | — | $2302.65 | ||
| Q3 24 | — | $-22.68 | ||
| Q2 24 | — | $-1920.85 | ||
| Q1 24 | — | $-535.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $207.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.8M | $245.2M |
| Total Assets | $23.3M | $277.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $207.6M | ||
| Q3 25 | $1.7M | $190.1M | ||
| Q2 25 | $1.2M | $125.3M | ||
| Q1 25 | $765.6K | $131.7M | ||
| Q4 24 | $2.2M | $98.8M | ||
| Q3 24 | $2.2M | $28.2M | ||
| Q2 24 | $2.6M | $4.2M | ||
| Q1 24 | $2.7M | $7.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | $8.7M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $10.8M |
| Q4 25 | $18.8M | $245.2M | ||
| Q3 25 | $20.0M | $231.1M | ||
| Q2 25 | $20.0M | $168.0M | ||
| Q1 25 | $20.4M | $180.4M | ||
| Q4 24 | $20.0M | $139.6M | ||
| Q3 24 | $23.7M | $74.2M | ||
| Q2 24 | $25.2M | $42.1M | ||
| Q1 24 | $25.2M | $108.1M |
| Q4 25 | $23.3M | $277.2M | ||
| Q3 25 | $24.0M | $252.4M | ||
| Q2 25 | $23.6M | $187.4M | ||
| Q1 25 | $24.1M | $192.9M | ||
| Q4 24 | $23.4M | $162.9M | ||
| Q3 24 | $26.4M | $95.0M | ||
| Q2 24 | $27.3M | $70.3M | ||
| Q1 24 | $27.8M | $135.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | 0.06× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.10× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $116.4K | $-39.6M |
| Free Cash FlowOCF − Capex | $24.3K | $-41.5M |
| FCF MarginFCF / Revenue | 0.4% | -770.4% |
| Capex IntensityCapex / Revenue | 1.5% | 34.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.6M | $-103.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $116.4K | $-39.6M | ||
| Q3 25 | $638.0K | $-28.8M | ||
| Q2 25 | $28.2K | $-14.8M | ||
| Q1 25 | $-2.0M | $-16.6M | ||
| Q4 24 | $-60.1K | $-14.6M | ||
| Q3 24 | $-58.2K | $-18.8M | ||
| Q2 24 | $363.5K | $-9.9M | ||
| Q1 24 | $-398.8K | $-17.6M |
| Q4 25 | $24.3K | $-41.5M | ||
| Q3 25 | $492.1K | $-29.7M | ||
| Q2 25 | $-22.8K | $-15.4M | ||
| Q1 25 | $-2.1M | $-16.6M | ||
| Q4 24 | $-118.1K | $-14.6M | ||
| Q3 24 | $-368.9K | $-18.8M | ||
| Q2 24 | $58.0K | — | ||
| Q1 24 | $-491.8K | $-17.7M |
| Q4 25 | 0.4% | -770.4% | ||
| Q3 25 | 6.7% | -904.1% | ||
| Q2 25 | -0.3% | -768.8% | ||
| Q1 25 | -28.3% | -682.8% | ||
| Q4 24 | -2.9% | -566.7% | ||
| Q3 24 | -5.3% | -666.5% | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | -6.3% | -712.4% |
| Q4 25 | 1.5% | 34.8% | ||
| Q3 25 | 2.0% | 29.2% | ||
| Q2 25 | 0.7% | 26.4% | ||
| Q1 25 | 0.6% | 0.2% | ||
| Q4 24 | 1.4% | 0.1% | ||
| Q3 24 | 4.5% | 0.3% | ||
| Q2 24 | 3.8% | 0.0% | ||
| Q1 24 | 1.2% | 4.4% |
| Q4 25 | — | — | ||
| Q3 25 | 9.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -5.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |